Design, synthesis, and validation of a novel [11c]promethazine pet probe for imaging abeta using autoradiography

2Citations
Citations of this article
13Readers
Mendeley users who have this article in their library.

Abstract

Promethazine, an antihistamine drug used in the clinical treatment of nausea, has been demonstrated the ability to bind Abeta in a transgenic mouse model of Alzheimer’s disease. However, so far, all of the studies were performed in vitro using extracted tissues. In this work, we report the design and synthesis of a novel [11C]promethazine PET radioligand for future in vivo studies. The [11C]promethazine was isolated by RP-HPLC with radiochemical purity >95% and molar activity of 48 TBq/mmol. The specificity of the probe was demonstrated using human hippocampal tissues via autoradiography.

Cite

CITATION STYLE

APA

Whitmore, C. A., Boules, M. I., Behof, W. J., Haynes, J. R., Koktysh, D., Rosenberg, A. J., … Pham, W. (2021). Design, synthesis, and validation of a novel [11c]promethazine pet probe for imaging abeta using autoradiography. Molecules, 26(8). https://doi.org/10.3390/molecules26082182

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free